Dc Investments Management, LLC Amgen Inc Transaction History

Dc Investments Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $202,857 - $232,152	-1,020 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $216,515 - $253,674	1,020 New	1,020 $217,000
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $734,454 - $816,773	-3,130 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $205,326 - $251,964	1,038 Added 49.62%	3,130 $738,000
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $41,550 - $55,107	228 Added 12.23%	2,092 $424,000
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $171,613 - $220,582	-907 Reduced 32.73%	1,864 $449,000
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $17,759 - $21,279	-102 Reduced 3.55%	2,771 $536,000
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $201,540 - $236,250	1,209 Added 72.66%	2,873 $529,000
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $296,857 - $346,528	1,664 New	1,664 $324,000
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $2.05 Million - $2.31 Million	-12,362 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$169.43 - $198.0 $1.45 Million - $1.69 Million	8,544 Added 223.78%	12,362 $2.11 Million
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $644,440 - $720,036	3,818	3,818 $664,000

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dc Investments Management, LLC with notifications on news.